Ube Corporation · TSE:4208
Ube — Q2 FY2018 Earnings Presentation
23 slides from Ube's earnings presentation, Nov 1, 2018
Slide 1: Financial Results for the 2nd Quarter FY2018
Financial Results for the 2nd Quarter FY2018 November 1, 2018 2nd Quarter: April – September
Slide 2: Scope of Consolidation
2nd Quarter of the FY2018 Scope of Consolidation End of FY2017 End of FY2018 2Q Difference Item Notes (A) (B) （B) - （A) Number of consolidated 70 71 1 + Oita Ube Co., Ltd. subsidiaries Number of equity method 24 24 0 affiliates Total 94 95 1 2
Slide 3: Environmental Factors
2nd Quarter of the FY2018 Environmental Factors FY2017 2Q FY2018 2Q Difference Item (A) (B) (B) - (A) Exchange Rate Yen/$ 111.1 110.3 (0.8) 463 646 183 Naphtha CIF $/ｔ Domestic Yen/KL 37,700 51,300 13,600 Material Price Benzene(ACP) $/ｔ 777 855 78 Australian $/ｔ 100.3 127.8 27.5 Coal (CIF) Yen/t 11,
Slide 4: Major P/L Items
2nd Quarter of the FY2018 Major P/L Items (Billions of yen) FY2017 2Q FY2018 2Q Difference Percentage Item (A) (B) (B) - (A) change Net sales 327.1 348.2 21.1 6.5% Operating profit 22.6 15.0 (7.5) (33.5)% Ordinary profit 23.7 18.6 (5.0) (21.2)% Profit attributable to 15.7 12.3 (3.4) (21.7)% owners o
Slide 5: Net Sales and Operating Profit by Segment
2nd Quarter of the FY2018 Net Sales and Operating Profit by Segment (Billions of yen) FY2017 2Q FY2018 2Q Difference Segment (A) (B) (B) - (A) Chemicals 146.3 151.6 5.3 Pharmaceutical 5.1 3.3 (1.7) Net sales Cement & Construction Materials 115.9 119.4 3.5 Machinery 35.7 43.2 7.4 Energy & Environment
Slide 6: Analysis - Total
2nd Quarter of the FY2018 Analysis - Total (Billions of yen) Net Sales Difference of operating profit Chemicals 5.3 500.0 +21.1 Pharmaceutical (1.7) Price ※1 (7.4) 348.2 Cement & Construction Materials 3.5 327.1 合成ゴム 69.0 Machinery 7.4 250.0 Energy & Environment 5.4 Volume 1.5 Others (0.0) Adjustmen
Slide 7: Analysis - Chemicals
2nd Quarter of the FY2018 Analysis - Chemicals (Billions of yen) Net Sales Difference of operating profit Nylon/Caprolactam chain 6.3 Price ※1 (6.8) +5.3 Synthetic rubber (2.5) 合成ゴム 69.0 Battery Materials and Fine Chemicals 1.0 Polyimide and Specialty Products 0.4 Volume 1.3 etc カプロラクタム (6 0) Fixed
Slide 8: Analysis - Pharmaceutical
2nd Quarter of the FY2018 Analysis - Pharmaceutical (Billions of yen) Net Sales Difference of operating profit (1.7) Price ※1 (0.1) Volume (0.0) (34.2)% Decreased Fixed Cost and Others ※2 (1.5) Operating profit Total (1.6) (1.6) *1: Including both selling and purchase change － *2: Including inventor
Slide 9: Analysis – Cement & Construction Materials
2nd Quarter of the FY2018 Analysis – Cement & Construction Materials (Billions of yen) Net Sales Difference of operating profit +3.5 Price ※1 (0.1) Cement and Ready-mixed concrete 2.6 69.0 Construction materials and 0.9 Limestone related products Volume 0.5 etc (6 0) 3.0% Increased Fixed Cost and Ot
Slide 10: Analysis - Machinery
2nd Quarter of the FY2018 Analysis - Machinery (Billions of yen) Net Sales Difference of operating profit +7.4 Price ※1 (0.4) 69.0 Volume 0.1 (6 0) 20.8% Increased Fixed Cost and Others ※2 0.4 Operating profit Total 0.0 0.0 *1: Including both selling and purchase change 3.1% Increased *2: Including
Slide 11: Analysis – Energy & Environment
2nd Quarter of the FY2018 Analysis – Energy & Environment (Billions of yen) Net Sales Difference of operating profit +5.4 Price ※1 (0.0) Coal 4.2 69.0 Power 1.3 Volume (0.3) (6 0) 16.7% Increased Fixed Cost and Others ※2 0.7 Operating profit Total 0.3 +0.3 Coal (0.1) Power 0.5 *1: Including both sel
Slide 12: Operating Profit – Profit attributable to owners of parent
2nd Quarter of the FY2018 Operating Profit – Profit attributable to owners of parent (Billions of yen) FY2017 2Q FY2018 2Q Difference Item (A) (B) (B) - (A) Operating profit 22.6 15.0 (7.5) Non-operating income/expenses 1.1 3.6 2.5 Net Interests expenses 0.1 1.1 0.9 Share of profit of entities accou
Slide 13: Consolidated Balance Sheet
2nd Quarter of the FY2018 Consolidated Balance Sheet (Billions of yen) End of FY2017 End of FY2018 2Q Difference Item (A) (B) (B) - (A) Current assets 316.8 310.2 (6.6) Fixed assets 425.4 424.0 (1.3) Total assets 742.4 734.4 (8.0) Interest-bearing debts 195.5 192.3 (3.2) Other liabilities 210.0 198.
Slide 14: Consolidated Statements of Cash Flows
2nd Quarter of the FY2018 Consolidated Statements of Cash Flows (Billions of yen) Item FY2017 2Q FY2018 2Q Profit before income taxes 17.6 A.Cash flows from operating activities 31.0 21.6 Depreciation and amortization 17.8 Income taxes paid (7.0), etc. B.Cash flows from investing activities (16.4) (
Slide 15: Net Sales and Operating Profit by Segment – Forecast/Result
2nd Quarter of the FY2018 Net Sales and Operating Profit by Segment – Forecast/Result (Billions of yen) FY2018 2Q FY2018 2Q Difference FY2018 full-year Segment forecast result (A) (B) (B) - (A) published on May 10 Chemicals 150.0 151.6 1.6 320.0 Pharmaceutical 4.0 3.3 (0.7) 10.0 Net sales Cement & C
Slide 16: Reference
Reference 16
Slide 17: Analysis of Operating Profit - All Segments
Reference: 2nd Quarter of the FY2018 Analysis of Operating Profit - All Segments （Billions of yen） Operating profit Segment Fixed cost FY2017 2Q FY2018 2Q Difference Price Volume and others (A) (B) (B) - (A) *1 *2 Chemicals 13.3 8.2 (5.0) (6.8) 1.3 0.4 Pharmaceutical 1.6 (0.0) (1.6) (0.1) (0.0) (1.5
Slide 18: Progress of Major P/L Items
Reference: 2nd Quarter of the FY2018 Progress of Major P/L Items (Billions of yen) FY2017 (A) FY2018 (B) Difference (B) - (A) Item 2Q 2Q 2Q Progress Progress 327.1 348.2 Net sales 695.5 740.0 44.5 21.1 47.0% 47.1% 22.6 15.0 Operating profit 50.2 44.0 (6.2) (7.5) 45.0% 34.1% 23.7 18.6 Ordinary profit
Slide 19: Net Sales
Reference: 2nd Quarter of the FY2018 Net Sales (Billions of yen) FY2018 Full-year Segment (Forecast) Progress 1Q 2Q 3Q 4Q Total Chemicals 73.5 78.1 - - 151.6 320.0 47.4% Pharmaceutical 1.7 1.6 - - 3.3 10.0 33.0% Cement & Construction 59.4 60.0 - - 119.4 250.0 47.8% Materials Machinery 18.7 24.4 - -
Slide 20: Operating Profit
Reference: 2nd Quarter of the FY2018 Operating Profit (Billions of yen) FY2018 Full-year Segment (Forecast) Progress 1Q 2Q 3Q 4Q Total Chemicals 3.6 4.6 - - 8.2 22.5 36.4% Pharmaceutical (0.0) 0.0 - - (0.0) 0.5 - Cement & Construction 2.0 2.5 - - 4.5 12.5 36.0% Materials Machinery 0.1 1.1 - - 1.3 6.
Slide 21: Consolidated Key Indicators
Reference: 2nd Quarter of the FY2018 Consolidated Key Indicators (Billions of yen) FY2018 full-year FY2017 Item FY2017 2Q FY2018 2Q (forecast) full-year Capital investment 13.8 17.0 40.0 40.3 Depreciation and amortization 17.2 17.8 37.0 35.3 R&D expenses 6.4 5.9 14.0 13.2 Adjusted operating profit 2
Slide 22: Consolidated Major Subsidiaries
Reference: 2nd Quarter of the FY2018 Consolidated Major Subsidiaries (Billions of yen) Net Difference of Sales operating Subsidiaries and affiliates Business profit from FY2018 2Q FY2017 2Q Manufacture and sales of caprolactam, ammonium sulfate, nylon, and UBE Corporation Europe, S.A. Unipersonal fi
Slide 23: Forward-looking statements disclaimer
This presentation material contains forward-looking statements concerning UBEʼs future plans, strategies, and performance. These forward-looking statements are not historical facts; rather, they represent assumptions and beliefs based on economic, financial, and competitive date currently available.